Guardant Health (GH) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.72. This compares to loss of $1.30 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 36.11%. A quarter ago, it was expected that this provider of oncology testing services would post a loss of $0.93 per share when it actually produced a loss of $1.58, delivering a surprise of -69.89%.Over the last four quart ...